• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    5 Value Stocks In The Consumer Defensive Sector

    3/1/24 9:40:14 AM ET
    $AGRO
    $MO
    $PRDO
    $SANW
    Farming/Seeds/Milling
    Consumer Staples
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $AGRO alert in real time by email

    The Meaning Behind Value Stocks

    A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

    The following stocks are considered to be notable value stocks in the consumer defensive sector:

    1. S&W Seed (NASDAQ:SANW) - P/E: 1.67
    2. Perdoceo Education (NASDAQ:PRDO) - P/E: 8.15
    3. Vector Group (NYSE:VGR) - P/E: 9.62
    4. Altria Group (NYSE:MO) - P/E: 8.95
    5. Adecoagro (NYSE:AGRO) - P/E: 7.34

    S&W Seed saw a decrease in earnings per share from -0.11 in Q1 to $-0.13 now. Perdoceo Education has reported Q4 earnings per share at $0.27, which has decreased by 57.81% compared to Q3, which was 0.64. Vector Group's earnings per share for Q4 sits at $0.36, whereas in Q3, they were at 0.33. Its most recent dividend yield is at 6.8%, which has decreased by 0.66% from 7.46% in the previous quarter.

    Altria Group has reported Q4 earnings per share at $1.18, which has decreased by 7.81% compared to Q3, which was 1.28. The company's most recent dividend yield sits at 9.21%, which has increased by 0.12% from 9.09% last quarter.

    Adecoagro has reported Q3 earnings per share at $0.83, which has increased by 107.5% compared to Q2, which was 0.4. Its most recent dividend yield is at 3.93%, which has increased by 0.21% from 3.72% in the previous quarter.

    These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

    Get the next $AGRO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGRO
    $MO
    $PRDO
    $SANW

    CompanyDatePrice TargetRatingAnalyst
    Adecoagro S.A.
    $AGRO
    1/9/2026$9.00Underperform → Neutral
    BofA Securities
    Altria Group Inc.
    $MO
    1/9/2026$63.00Neutral → Buy
    UBS
    Adecoagro S.A.
    $AGRO
    12/1/2025$7.00Underweight
    Analyst
    Altria Group Inc.
    $MO
    7/9/2025$50.00Underperform
    Jefferies
    Altria Group Inc.
    $MO
    7/2/2025$59.00Sell → Neutral
    UBS
    Adecoagro S.A.
    $AGRO
    4/28/2025$10.00Equal-Weight → Underweight
    Morgan Stanley
    Adecoagro S.A.
    $AGRO
    4/25/2025$12.00 → $10.80Buy → Underperform
    BofA Securities
    Altria Group Inc.
    $MO
    4/1/2025Buy → Hold
    Deutsche Bank
    More analyst ratings

    $AGRO
    $MO
    $PRDO
    $SANW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Altria to Present at the 2026 Consumer Analyst Group of New York Conference

    Altria Group, Inc. (Altria) (NYSE:MO) will host a webcast of its business presentation at the annual Consumer Analyst Group of New York conference in Orlando, Florida, on Wednesday, February 18, 2026, at approximately 1:00 p.m. Eastern Time. The webcast will feature a presentation by Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Altria's Executive Vice President and Chief Financial Officer. The webcast will be in a listen-only mode. Pre-event registration is necessary; directions are posted at www.altria.com/webcasts. An archived copy of the webcast will be available on altria.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260

    2/4/26 10:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Perdoceo Education Corporation Schedules Fourth Quarter Earnings Conference Call for February 19th

    Perdoceo Education Corporation (NASDAQ:PRDO), a provider of postsecondary education programs, today announced it will report fourth quarter and full year 2025 financial results after the market closes on Thursday, February 19, 2026. The Company will host a live conference call and webcast to discuss the results and its 2026 outlook later that evening at 5:00 p.m. Eastern time. Interested parties can access the live webcast of the conference call at www.perdoceoed.com in the Investor Relations section of the website. Participants can also listen to the conference call by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international). Both dial-in numbers will use the access code 46712

    1/29/26 4:15:00 PM ET
    $PRDO
    Other Consumer Services
    Real Estate

    Altria Reports 2025 Fourth-Quarter and Full-Year Results; Provides 2026 Earnings Guidance

    Altria Group, Inc. (NYSE:MO) today reports our 2025 fourth-quarter and full-year business results and provides our guidance for 2026 full-year adjusted diluted earnings per share (EPS). "2025 was a year of continued momentum for Altria, marked by strong financial performance, strategic progress across our smoke-free portfolio, new relationships in support of our long-term growth goals and significant cash returns to shareholders," said Billy Gifford, Altria's Chief Executive Officer. "For the full year, we grew adjusted diluted earnings per share by 4.4% and returned $8 billion to shareholders through dividends and share repurchases combined." "We expect to deliver 2026 full-year adjust

    1/29/26 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $AGRO
    $MO
    $PRDO
    $SANW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Adecoagro S.A. upgraded by BofA Securities with a new price target

    BofA Securities upgraded Adecoagro S.A. from Underperform to Neutral and set a new price target of $9.00

    1/9/26 9:17:24 AM ET
    $AGRO
    Farming/Seeds/Milling
    Consumer Staples

    Altria upgraded by UBS with a new price target

    UBS upgraded Altria from Neutral to Buy and set a new price target of $63.00

    1/9/26 8:23:08 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Analyst resumed coverage on Adecoagro S.A. with a new price target

    Analyst resumed coverage of Adecoagro S.A. with a rating of Underweight and set a new price target of $7.00

    12/1/25 8:24:44 AM ET
    $AGRO
    Farming/Seeds/Milling
    Consumer Staples

    $AGRO
    $MO
    $PRDO
    $SANW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Davis Robert Matthews bought $48,599 worth of shares (1,200 units at $40.50), increasing direct ownership by 16% to 8,473 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    11/8/23 3:08:44 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Clarke Ian L.T. bought $44,625 worth of shares (1,100 units at $40.57), increasing direct ownership by 18% to 7,145 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    11/8/23 3:03:21 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $AGRO
    $MO
    $PRDO
    $SANW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Gifford William F. Jr. gifted 15,700 shares, decreasing direct ownership by 2% to 673,427 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    2/6/26 2:55:27 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by Director Munoz George

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    1/20/26 5:03:46 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    President and CEO Nelson Todd S sold $3,522,000 worth of shares (120,000 units at $29.35), decreasing direct ownership by 23% to 404,047 units (SEC Form 4)

    4 - PERDOCEO EDUCATION Corp (0001046568) (Issuer)

    12/17/25 4:22:15 PM ET
    $PRDO
    Other Consumer Services
    Real Estate

    $AGRO
    $MO
    $PRDO
    $SANW
    SEC Filings

    View All

    Altria Group Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ALTRIA GROUP, INC. (0000764180) (Filer)

    1/29/26 7:20:21 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - ALTRIA GROUP, INC. (0000764180) (Filer)

    1/29/26 7:04:06 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Perdoceo Education Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - PERDOCEO EDUCATION Corp (0001046568) (Filer)

    1/5/26 8:30:33 AM ET
    $PRDO
    Other Consumer Services
    Real Estate

    $AGRO
    $MO
    $PRDO
    $SANW
    Leadership Updates

    Live Leadership Updates

    View All

    Altria Group, Inc. Announces Retirement of CEO Billy Gifford and Appointment of Sal Mancuso as Successor

    Altria Group, Inc. (Altria) (NYSE:MO) announces today that Billy Gifford, Altria's Chief Executive Officer (CEO), has decided to retire, effective May 14, 2026 at the conclusion of the 2026 Annual Meeting of Shareholders (2026 Annual Meeting). Billy has had a distinguished career of over 30 years with the Altria family of companies and has served as Altria's CEO since 2020. Altria's Board of Directors (Board) has elected Salvatore (Sal) Mancuso to serve as Altria's CEO upon Billy's retirement. To facilitate a smooth transition, Billy plans to serve as a consultant to Altria upon his retirement through at least the end of 2026. Additionally, the Board elected Heather Newman to serve as Altri

    12/11/25 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Group, Inc. Announces Retirement of Director George Muñoz from Board of Directors

    Altria Group, Inc. (Altria) (NYSE:MO) -- George Muñoz, a director of Altria since 2004, notified Altria of his decision to retire from service on our Board of Directors (Board) following the completion of his current term. Consequently, Mr. Muñoz will not stand for re-election to our Board at our 2026 Annual Meeting of Shareholders, which Altria anticipates holding on May 14, 2026. "George has made extensive and significant contributions to Altria over more than 20 years," said Kathryn McQuade, Altria's independent Chair of the Board. "We thank George for his long-standing and valuable service and wish him the very best upon his retirement." Mr. Muñoz is Chair of the Compensation and Ta

    10/9/25 8:35:00 AM ET
    $LAUR
    $MO
    Other Consumer Services
    Real Estate
    Medicinal Chemicals and Botanical Products
    Health Care

    Hims & Hers Health Set to Join S&P SmallCap 600

    NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, October 9. JT Group is acquiring Vector Group in a deal expected to close soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector October 9, 2024 S&P SmallCap 600 Addition Hims & Hers Health HIMS Health Care S&P SmallCap 600 Deletion Vector Group VGR Consumer Staples For more information about S&P Dow Jones Indices, please visit www.spdji.com

    10/4/24 6:05:00 PM ET
    $HIMS
    $SPGI
    $VGR
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    $AGRO
    $MO
    $PRDO
    $SANW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by S&W Seed Company

    SC 13D/A - S&W Seed Co (0001477246) (Subject)

    11/20/24 7:34:11 PM ET
    $SANW
    Farming/Seeds/Milling
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Adecoagro S.A.

    SC 13D/A - Adecoagro S.A. (0001499505) (Subject)

    11/18/24 8:27:58 PM ET
    $AGRO
    Farming/Seeds/Milling
    Consumer Staples

    SEC Form SC 13G filed by Adecoagro S.A.

    SC 13G - Adecoagro S.A. (0001499505) (Subject)

    11/14/24 4:14:20 PM ET
    $AGRO
    Farming/Seeds/Milling
    Consumer Staples

    $AGRO
    $MO
    $PRDO
    $SANW
    Financials

    Live finance-specific insights

    View All

    Perdoceo Education Corporation Schedules Fourth Quarter Earnings Conference Call for February 19th

    Perdoceo Education Corporation (NASDAQ:PRDO), a provider of postsecondary education programs, today announced it will report fourth quarter and full year 2025 financial results after the market closes on Thursday, February 19, 2026. The Company will host a live conference call and webcast to discuss the results and its 2026 outlook later that evening at 5:00 p.m. Eastern time. Interested parties can access the live webcast of the conference call at www.perdoceoed.com in the Investor Relations section of the website. Participants can also listen to the conference call by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international). Both dial-in numbers will use the access code 46712

    1/29/26 4:15:00 PM ET
    $PRDO
    Other Consumer Services
    Real Estate

    Altria Reports 2025 Fourth-Quarter and Full-Year Results; Provides 2026 Earnings Guidance

    Altria Group, Inc. (NYSE:MO) today reports our 2025 fourth-quarter and full-year business results and provides our guidance for 2026 full-year adjusted diluted earnings per share (EPS). "2025 was a year of continued momentum for Altria, marked by strong financial performance, strategic progress across our smoke-free portfolio, new relationships in support of our long-term growth goals and significant cash returns to shareholders," said Billy Gifford, Altria's Chief Executive Officer. "For the full year, we grew adjusted diluted earnings per share by 4.4% and returned $8 billion to shareholders through dividends and share repurchases combined." "We expect to deliver 2026 full-year adjust

    1/29/26 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Declares Regular Quarterly Dividend of $1.06 Per Share

    Altria Group, Inc. (NYSE:MO) today announced that our Board of Directors declared a regular quarterly dividend of $1.06 per share, payable on January 9, 2026 to shareholders of record as of December 26, 2025. The ex-dividend date is December 26, 2025. View source version on businesswire.com: https://www.businesswire.com/news/home/20251210780457/en/ Altria Client Services Investor Relations 804-484-8222 Altria Client Services Media Relations 804-484-8897 www.altria.com/contact-us/media

    12/10/25 1:30:00 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care